The role of the ROCK1 pathway is not limited to the control of actin cytoskeletal dynamics, but also plays a central role in suppressing apoptosis, potentiating cell survival and is significantly associated with poor prognosis in HER2+-BC patients40–44. The gene discussed is ERBB2; the disease is breast cancer.